Use of Unique Linkers to Control DAR & Mitigate Associated ADC Toxicity for Potential Use in Combination with Existing Anticancer Treatments
1:30 pm - Monday 8th March 2027
- Sharing a general ADC concept and linker technology approach
- Presenting the Taiho & Araris-based programs with our approach and strategy
- Determining potential usability of combinations with existing anticancer treatments